CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-03 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −104 | $2.82 | $293 | 93,519 |
| 2023-03-20 | Amoroso Michael Director | Sale | −268 | $2.33 | $624 | 56,441 |
| 2023-03-15 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −792 | $2.60 | $2K | 94,458 |
| 2023-03-03 | Amoroso Michael Director | Sale | −1,002 | $2.38 | $2K | 56,709 |
| 2023-03-03 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −207 | $2.28 | $472 | 93,623 |
| 2022-12-09 | O'Malley Brendan M. SVP, General Counsel | Purchase | +5,869 | $3.13 | $18K | 93,830 |
| 2022-11-18 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +2,500 | $4.00 | $10K | 95,250 |
| 2022-11-18 | O'Malley Brendan M. SVP, General Counsel | Purchase | +7,500 | $3.99 | $30K | 87,961 |
| 2022-10-17 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −207 | $4.30 | $890 | 165,732 |
| 2022-09-28 | O'Malley Brendan M. SVP, General Counsel | Grant or award | +72,750 | 80,461 | ||
| 2022-09-28 | Seshadri Vishwas Chief Executive Officer | Grant or award | +155,200 | 165,939 | ||
| 2022-09-28 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +72,750 | 92,750 | ||
| 2022-09-26 | Charles Faith L. Director | Grant or award | +13,400 | 20,414 | ||
| 2022-09-26 | Alland Leila Director | Grant or award | +13,400 | 20,414 | ||
| 2022-09-26 | Silverstein Christine Berni Director | Grant or award | +13,400 | 35,525 | ||
| 2022-09-26 | Amoroso Michael Director | Grant or award | +13,400 | 57,711 | ||
| 2022-09-26 | Wider Todd Director | Grant or award | +13,400 | 16,907 | ||
| 2022-09-26 | Mann Paul Elliot Director | Grant or award | +13,400 | 16,907 | ||
| 2022-09-26 | Alvino Mark Director | Grant or award | +13,400 | 18,414 | ||
| 2022-09-26 | Wuchterl Donald A. Director | Grant or award | +13,400 | 20,414 |
Page 9 of 12 · 223 trades